CRISPR/Cas9 and iPSC-Based Therapeutic Approaches in Alzheimer’s Disease

CRISPR/Cas9 and iPSC-Based Therapeutic Approaches in Alzheimer’s Disease

Alzheimer’s disease (AD), the leading cause of dementia, remains poorly understood despite decades of intensive research, which continues to hinder the development of effective treatments. As a complex multifactorial disorder, AD lacks a cure to halt the progressive neurodegeneration, and the precis...

Full description

Saved in:
Bibliographic Details
Main Authors: Ivana Raffaele, Giovanni Luca Cipriano, Ivan Anchesi, Salvatore Oddo, Serena Silvestro
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Antioxidants
Subjects:
Alzheimer’s disease
CRISPR/Cas9
genome editing
stem cell
aging
neuroinflammation
Online Access:https://www.mdpi.com/2076-3921/14/7/781
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items